Jiang J, Sigmund AM, Zhao Q, Elder P, Benson DM, Vasu S, et al. Longitudinal survival outcomes in allogeneic stem cell transplantation: an institutional experience. Cancers. 2022;14.

Nannya Y, Viswabandya A, Lu P. Advances in allogeneic hematopoietic stem cell transplantation for acute leukemia. Blood Cell Ther. 2022;5:S25–s33.

PubMed  PubMed Central  Google Scholar 

Bhatia S. Cause-specific late mortality after allogeneic stem cell transplantation. Hematol Am Soc Hematol Educ Program. 2019;2019:626–9.

Article  Google Scholar 

Harrison RA, Sharafeldin N, Rexer JL, Streck B, Petersen M, Henneghan AM, et al. Neurocognitive Impairment After Hematopoietic Stem Cell Transplant for Hematologic Malignancies: Phenotype and Mechanisms. Oncologist. 2021;26:e2021–e33.

Article  PubMed  PubMed Central  Google Scholar 

Mitchell AJ, Ferguson DW, Gill J, Paul J, Symonds P. Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol. 2013;14:721–32.

Article  PubMed  Google Scholar 

Pidala J, Anasetti C, Jim H. Quality of life after allogeneic hematopoietic cell transplantation. Blood. 2009;114:7–19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pulewka K, Strauss B, Hochhaus A, Hilgendorf I. Clinical, social, and psycho-oncological needs of adolescents and young adults (AYA) versus older patients following hematopoietic stem cell transplantation. J Cancer Res Clin Oncol. 2021;147:1239–46.

Article  PubMed  Google Scholar 

Redondo S, De Dios A, Gomis-Pastor M, Esquirol A, Aso O, Triquell M, et al. Feasibility of a new model of care for allogeneic stem cell transplantation recipients facilitated by eHealth: the MY-Medula pilot study. Transplant Cell Ther. 2023;29(6):385.e1–.e8.

Article  PubMed  Google Scholar 

Hayes CA, Meehan KR, O’Donnell EA, Van Citters A, Caldon KL, Coughenour CM, et al. Patient reported outcomes for patients receiving a hematopoietic stem cell transplant: a longitudinal assessment with a dashboard display. Blood. 2022;140(Supplement 1):8113–4.

Article  Google Scholar 

Yu Z-P, Ding J-H, Wu F, Liu J, Wang J, Cheng J, et al. Quality of life of patients after allogeneic hematopoietic stem cell transplantation with antihuman thymocyte globulin. Biology Blood Marrow Transpl. 2012;18:593–9.

Article  CAS  Google Scholar 

Amonoo HL, Johnson PC, Dhawale TM, Traeger L, Rice J, Lavoie MW, et al. Sharing and caring: The impact of social support on quality of life and health outcomes in hematopoietic stem cell transplantation. Cancer. 2021;127:1260–5.

Article  PubMed  Google Scholar 

Zhang X, Wang J, Liu Y, Liu J, Wang B, Zhang Q, et al. Long-term survivors demonstrate superior quality of life after haploidentical stem cell transplantation to matched sibling donor transplantation. J Transl Med. 2022;20:596.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hilgendorf I, Greinix H, Halter JP, Lawitschka A, Bertz H, Wolff D. Long-term follow-up after allogeneic stem cell transplantation. Dtsch Arztebl Int. 2015;112:51–8.

PubMed  PubMed Central  Google Scholar 

PD Dr. med. Francis Ayuk HPDmGB, Frankfurt a. M.; PD Dr. med. Phi-, lipp Hemmati BPDmIH, Jena; Prof. Dr. med. André Tichelli, Basel; Dr. med., Eva-Maria Wagner M. Langzeitnachsorge nach SZT. Leitlinien zur allogenen Stammzelltransplantation von der Deutschen Arbeitsgemeinschaft für Knochenmark- und Blutstammzelltransplantation (DAG-KBT). Version 1 ed. Hamburg 2016.

Redaelli A, Stephens JM, Brandt S, Botteman MF, Pashos CL. Short- and long-term effects of acute myeloid leukemia on patient health-related quality of life. Cancer Treat Rev. 2004;30:103–17.

Article  PubMed  Google Scholar 

Belec RH. Quality of life: perceptions of long-term survivors of bone marrow transplantation. Oncol Nurs Forum. 1992;19:31–7.

CAS  PubMed  Google Scholar 

Lee SJ, Fairclough D, Parsons SK, Soiffer RJ, Fisher DC, Schlossman RL, et al. Recovery after stem-cell transplantation for hematologic diseases. J Clin Oncol. 2001;19:242–52.

Article  CAS  PubMed  Google Scholar 

Syrjala KL, Langer SL, Abrams JR, Storer BE, Martin PJ. Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J Clin Oncol. 2005;23:6596–606.

Article  PubMed  Google Scholar 

Messerer D, Engel J, Hasford J, Schaich M, Ehninger G, Sauerland C, et al. Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia. Haematologica. 2008;93:826–33.

Article  PubMed  Google Scholar 

Andrykowski MA, Bishop MM, Hahn EA, Cella DF, Beaumont JL, Brady MJ, et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol. 2005;23:599–608.

Article  PubMed  Google Scholar 

Bevans MF, Mitchell SA, Barrett AJ, Bishop M, Childs R, Fowler D, et al. Function, adjustment, quality of life and symptoms (FAQS) in allogeneic hematopoietic stem cell transplantation (HSCT) survivors: a study protocol. Health Qual Life Outcomes. 2011;9:24.

Article  PubMed  PubMed Central  Google Scholar 

Carreras E, Dufour C, Mohty M, Kröger N. Hematopoietic stem cell transplantation and cellular therapies. The EBMT Handbook. Cham (CH): Springer Copyright 2019, The Editor(s) (if applicable) and The Author(s). 2019.

Harris AC, Young R, Devine S, Hogan WJ, Ayuk F, Bunworasate U, et al. International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium. Biol Blood Marrow Transpl. 2016;22:4–10.

Article  Google Scholar 

Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transpl. 2015;21:389–401.e1.

Article  Google Scholar 

Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A, et al. EORTC QLQ-C30 Scoring Manual (3rd edition). Brussels: EORTC, 2001.

Smith AB. Functional Assessment of Cancer Therapy (FACT). In: Michalos AC, editor. Encyclopedia of Quality of Life and Well-Being Research. Dordrecht: Springer Netherlands; 2014. p. 2367–70.

Lee SJ, Logan B, Westervelt P, Cutler C, Woolfrey A, Khan SP, et al. Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation: Long-term Follow-up of a Randomized Clinical Trial. JAMA Oncol. 2016;2:1583–9.

Article  PubMed  PubMed Central  Google Scholar 

Nolte S, Waldmann A, Liegl G, Petersen MA, Groenvold M, Rose M. Updated EORTC QLQ-C30 general population norm data for Germany. Eur J Cancer. 2020;137:161–70.

Article  PubMed  Google Scholar 

Janda M, DiSipio T, Hurst C, Cella D, Newman B. The Queensland Cancer Risk Study: general population norms for the Functional Assessment of Cancer Therapy-General (FACT-G). Psychooncology. 2009;18:606–14.

Article  PubMed  Google Scholar 

Breen S, Kofoed S, Ritchie D, Dryden T, Maguire R, Kearney N, et al. Remote real-time monitoring for chemotherapy side-effects in patients with blood cancers. Collegian. 2017;24:541–9.

Article  Google Scholar 

Albelda R, Wiemers E, Hahn T, Khera N, Salas Coronado DY, Abel GA. Relationship between paid leave, financial burden, and patient-reported outcomes among employed patients who have undergone bone marrow transplantation. Qual Life Res. 2019;28:1835–47.

Article  PubMed  PubMed Central  Google Scholar 

Kirchhoff AC, Leisenring W, Syrjala KL. Prospective predictors of return to work in the 5 years after hematopoietic cell transplantation. J Cancer Surviv. 2010;4:33–44.

Article  PubMed  PubMed Central  Google Scholar 

Jim HS, Small B, Hartman S, Franzen J, Millay S, Phillips K, et al. Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation. Cancer. 2012;118:3407–16.

Article  PubMed  Google Scholar 

Sharafeldin N, Bosworth A, Patel SK, Chen Y, Morse E, Mather M, et al. Cognitive functioning after hematopoietic cell transplantation for hematologic malignancy: results from a prospective longitudinal study. J Clin Oncol. 2018;36:463–75.

Article  CAS  PubMed  Google Scholar 

Lee SJ, Kim HT, Ho VT, Cutler C, Alyea EP, Soiffer RJ, et al. Quality of life associated with acute and chronic graft-versus-host disease. Bone Marrow Transpl. 2006;38:305–10.

Article  CAS  Google Scholar 

Boyiadzis M, Arora M, Klein JP, Hassebroek A, Hemmer M, Urbano-Ispizua A, et al. Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia. Clin Cancer Res. 2015;21:2020–8.

Article  PubMed  Google Scholar 

Malard F, Holler E, Sandmaier BM, Huang H, Mohty M. Acute graft-versus-host disease. Nat Rev Disease Primers. 2023;9:27.

Article  PubMed  Google Scholar 

Jagasia M, Giglia J, Chinratanalab W, Dixon S, Chen H, Frangoul H, et al. Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria. Biol Blood Marrow Transpl. 2007;13:1207–15.

Article